12,212 Shares in CME Group Inc. $CME Acquired by Performance Wealth Partners LLC

Performance Wealth Partners LLC purchased a new stake in CME Group Inc. (NASDAQ:CME) in the second quarter, Holdings Channel.com reports. The institutional investor purchased 12,212 shares of the financial services provider’s stock, valued at approximately $2,697,000.

Other hedge funds also recently added to or reduced their stakes in the company. Asset Dedication LLC lifted its position in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after buying an additional 37 shares during the last quarter. Northwestern Mutual Investment Management Company LLC grew its position in shares of CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after buying an additional 37 shares during the last quarter. Rehmann Capital Advisory Group grew its position in shares of CME Group by 4.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after buying an additional 37 shares during the last quarter. Endowment Wealth Management Inc. grew its position in shares of CME Group by 4.4% in the 4th quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after buying an additional 38 shares during the last quarter. Finally, NBT Bank N A NY raised its stake in CME Group by 2.3% during the 1st quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock worth $492,000 after acquiring an additional 38 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Trading Down 0.7%

Shares of CME Group stock opened at $267.88 on Tuesday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $96.32 billion, a P/E ratio of 22.72, a PEG ratio of 3.14 and a beta of 0.23. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The company’s fifty day moving average is $250.51 and its two-hundred day moving average is $280.07.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the firm earned $2.96 earnings per share. The business’s quarterly revenue was up .8% compared to the same quarter last year. Analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 44.11%.

Insider Buying and Selling at CME Group

In related news, Director William R. Shepard bought 325 shares of the stock in a transaction on Thursday, June 25th. The shares were bought at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the purchase, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Weiss Ratings downgraded shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Raymond James Financial reiterated an “outperform” rating and set a $320.00 target price on shares of CME Group in a research report on Thursday, July 2nd. Deutsche Bank Aktiengesellschaft reduced their target price on CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. Rothschild & Co Redburn upgraded CME Group from a “neutral” rating to a “buy” rating and raised their price target for the stock from $316.00 to $323.00 in a research note on Thursday, June 11th. Finally, UBS Group dropped their price target on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a research note on Monday, July 6th. Ten investment analysts have rated the stock with a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $291.81.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.